Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 1
1948 2
1950 1
1953 3
1954 1
1956 4
1958 3
1959 2
1960 2
1961 1
1963 2
1964 2
1965 4
1967 5
1968 1
1969 6
1970 1
1971 3
1972 2
1973 7
1974 4
1975 1
1976 5
1977 4
1978 5
1979 6
1980 4
1981 3
1982 6
1983 7
1984 5
1985 2
1986 7
1987 7
1988 4
1989 9
1990 8
1991 12
1992 15
1993 27
1994 26
1995 16
1996 17
1997 19
1998 8
1999 15
2000 14
2001 14
2002 14
2003 17
2004 20
2005 15
2006 17
2007 15
2008 17
2009 16
2010 16
2011 20
2012 27
2013 17
2014 16
2015 17
2016 25
2017 16
2018 13
2019 26
2020 30
2021 28
2022 28
2023 21
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators. Modi S, et al. Among authors: perrin c. N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11. N Engl J Med. 2020. PMID: 31825192 Free PMC article. Clinical Trial.
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, Bergstrom EN, Kim J, Liu X, Blazquez-Encinas R, Giacobi C, Le Stang N, Boyault S, Cuenin C, Tabone-Eglinger S, Damiola F, Voegele C, Ardin M, Michallet MC, Soudade L, Delhomme TM, Poret A, Brevet M, Copin MC, Giusiano-Courcambeck S, Damotte D, Girard C, Hofman V, Hofman P, Mouroux J, Cohen C, Lacomme S, Mazieres J, de Montpreville VT, Perrin C, Planchard G, Rousseau N, Rouquette I, Sagan C, Scherpereel A, Thivolet F, Vignaud JM, Jean D, Ilg AGS, Olaso R, Meyer V, Boland-Auge A, Deleuze JF, Altmuller J, Nuernberg P, Ibáñez-Costa A, Castaño JP, Lantuejoul S, Ghantous A, Maussion C, Courtiol P, Hernandez-Vargas H, Caux C, Girard N, Lopez-Bigas N, Alexandrov LB, Galateau-Salle F, Foll M, Fernandez-Cuesta L. Mangiante L, et al. Among authors: perrin c. Nat Genet. 2023 Apr;55(4):607-618. doi: 10.1038/s41588-023-01321-1. Epub 2023 Mar 16. Nat Genet. 2023. PMID: 36928603 Free PMC article.
ipso.
Perrin CL. Perrin CL. J Org Chem. 2021 Nov 5;86(21):14245-14249. doi: 10.1021/acs.joc.1c02128. Epub 2021 Oct 22. J Org Chem. 2021. PMID: 34676769
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.
Jerusalem G, Park YH, Yamashita T, Hurvitz SA, Modi S, Andre F, Krop IE, Gonzàlez Farré X, You B, Saura C, Kim SB, Osborne CR, Murthy RK, Gianni L, Takano T, Liu Y, Cathcart J, Lee C, Perrin C. Jerusalem G, et al. Among authors: perrin c. Cancer Discov. 2022 Dec 2;12(12):2754-2762. doi: 10.1158/2159-8290.CD-22-0837. Cancer Discov. 2022. PMID: 36255231 Free PMC article.
Prediction of Early Neurological Deterioration in Individuals With Minor Stroke and Large Vessel Occlusion Intended for Intravenous Thrombolysis Alone.
Seners P, Ben Hassen W, Lapergue B, Arquizan C, Heldner MR, Henon H, Perrin C, Strambo D, Cottier JP, Sablot D, Girard Buttaz I, Tamazyan R, Preterre C, Agius P, Laksiri N, Mechtouff L, Béjot Y, Duong DL, Mounier-Vehier F, Mione G, Rosso C, Lucas L, Papassin J, Aignatoaie A, Triquenot A, Carrera E, Niclot P, Obadia A, Lyoubi A, Garnier P, Crainic N, Wolff V, Tracol C, Philippeau F, Lamy C, Soize S, Baron JC, Turc G; MINOR-STROKE Collaborators. Seners P, et al. Among authors: perrin c. JAMA Neurol. 2021 Mar 1;78(3):321-328. doi: 10.1001/jamaneurol.2020.4557. JAMA Neurol. 2021. PMID: 33427887 Free PMC article.
Le carcinome rénal à cellules claires (CRCC) sans altération du gène de Von Hippel-Lindau (VHL) : une entité anatomo-clinique à part ?
Brunot A, Dagher J, Perrin C, Patard JJ, Bensalah K, Verhoest G, Belaud-Rotureau M, Jouan F, Rioux-Leclercq N, Kammerer-Jacquet S. Brunot A, et al. Among authors: perrin c. Prog Urol. 2014 Nov;24(13):835. doi: 10.1016/j.purol.2014.08.114. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461641 French. No abstract available.
Therapeutic innovations in breast cancer.
Le Du F, Perrin C, Brunot A, Crouzet L, De La Motte Rouge T, Lefeuvre-Plesse C, Dieras V. Le Du F, et al. Among authors: perrin c. Presse Med. 2019 Oct;48(10):1131-1137. doi: 10.1016/j.lpm.2019.04.005. Epub 2019 May 29. Presse Med. 2019. PMID: 31151842 Review.
Hemolysis by surfactants--A review.
Manaargadoo-Catin M, Ali-Cherif A, Pougnas JL, Perrin C. Manaargadoo-Catin M, et al. Among authors: perrin c. Adv Colloid Interface Sci. 2016 Feb;228:1-16. doi: 10.1016/j.cis.2015.10.011. Epub 2015 Nov 11. Adv Colloid Interface Sci. 2016. PMID: 26687805 Review.
716 results